PDMP Toolkit

 描述（由申请人提供）：处方药监测计划（PDMP）是应对美国处方阿片类药物相关发病率流行的国家努力的核心 and mortality.然而，有证据表明，由于处方者和药剂师的使用不足，它们的全部潜力尚未实现。PDMP已在49个州实施，以打击处方药滥用和改善患者安全，但由于药剂师对如何将处方药纳入药学实践的指导很少，PDMP尚未发挥其作为临床决策工具的潜力。该项目的长期目标是通过提高社区药剂师的技能和资源来减少阿片类药物相关的危害，使他们能够有效地筛选，沟通并最终减少不安全的阿片类药物分配。为响应PA-04-002（“通过安全用药推进患者安全实施”），本研究的目的是开发社区药房PALGORY工具包，用于识别阿片类药物处方存在安全风险的患者，在护理点与患者沟通，并与主要处方者协调，以最大限度地提高患者使用阿片类镇痛剂的安全性。该工具包中的信息将使社区药剂师能够将PAPPINE整合到他们的工作流程中，识别有阿片类药物相关危害风险的患者，接近有顾虑的患者，并与他们的主要处方者协调护理。中心假设是，加强PDMP在社区药房实践中的整合将导致增加阿片类药物的使用，并最终更安全的阿片类药物分配。该假设将通过三个具体目标进行测试：本研究的第一个目标是开发Pestival工具包，包括社区药剂师如何在护理点有效使用Pestival以提高患者安全性并减少阿片类药物相关危害的政策和程序。药剂师、处方医生和患者的焦点小组将为工具包的开发提供信息。第二个目标是在六个社区药店实施PAPONS工具包，并评估该工具包对药剂师的知识，态度，自我效能和阿片类药物配药安全性的看法的影响。第三个目的是评价PAPK工具包的实施是否导致更安全的阿片类药物使用。这个项目是创新的，因为它挑战药剂师提升他们的临床实践，以提高病人的安全性和减少阿片类药物相关的危害的目标。完成后，开发的Pingdom工具包将立即在许多社区药房环境中可用。

 DESCRIPTION (provided by applicant): Prescription drug monitoring programs (PDMPs) are a centerpiece of state efforts to confront the US epidemic of prescription opioid-related morbidity and mortality. However, evidence suggests their full potential has not been realized because of prescriber and pharmacist underuse. PDMPs have been implemented in 49 states to combat prescription drug abuse and improve patient safety, but because pharmacists have little guidance about how to integrate the PDMP into pharmacy practice, PDMPs have not their fulfilled their potential as a clinical decision tool. The long-term goal of this project is to redce opioid-related harms by improving skills and resources available to community pharmacists so they can effectively screen, communicate, and ultimately reduce unsafe opioid dispensing. In response to PA-04-002 ("Advancing Patient Safety Implementation through Safe Medication Use"), the objective of this study is to develop a community pharmacy PDMP toolkit for identifying patients for whom dispensing an opioid prescription presents a safety risk, communicating with patients at the point of care, and coordinating with the primary prescriber to maximize patient safety in the use of opioid analgesics. Information in the toolkit will enable community pharmacists to integrate the PDMP into their workflow, identify patients at risk for opioid-related harms, approach patients with concerns, and coordinate care with their primary prescribers. The central hypothesis is that enhancing the integration of PDMPs in community pharmacy practice will lead to increased PDMP use and ultimately safer opioid dispensing. This hypothesis will be tested through three specific aims: The first aim of this study is to develop th PDMP toolkit, including policies and procedures for how community pharmacists can effectively use PDMP at the point of care to increase patient safety and reduce opioid-related harms. Focus groups of pharmacists, prescribers, and patients will inform development of the toolkit. The second aim is to implement the PDMP toolkit in six community pharmacies and evaluate the impact of the toolkit on pharmacists' knowledge, attitudes, self-efficacy, and perceptions of opioid dispensing safety. The third aim is to evaluate whether implementation of the PDMP toolkit results in safer opioid use. This project is innovative because it challenges pharmacists t elevate their clinical practice with the goal of improving patient safety and reducing opioid- related harms. Upon completion, the developed PDMP toolkit will be immediately available and usable in many community pharmacy settings.